Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA. It is available from one supplier. There are three patents…
Posts published in “Patent Expiration”
Annual Drug Patent Expirations for PROBUPHINE Probuphine is a drug marketed by Titan Pharms and is included in one NDA. There is one patent protecting this drug. This drug has…
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA. It is available from one supplier. There are sixteen patents…
Annual Drug Patent Expirations for RAYOS Rayos is a drug marketed by Horizon and is included in one NDA. It is available from one supplier. There are six patents protecting…
SOOLANTRA (ivermectin) Galderma labs lp Patent: 7,550,440 Expiration: Apr 22, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…
Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are twelve…
Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in one NDA. There are five patents protecting this drug and…
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are fourteen…
Annual Drug Patent Expirations for EVEKEO+ODT Evekeo Odt is a drug marketed by Azurity and is included in one NDA. There are four patents protecting this drug. EVEKEO ODT drug…